Sign up to save your podcasts
Or
Share Peter Maybarduk on Paxlovid, Maya Schenwar on Grassroots Journalism
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Peter Maybarduk on Paxlovid, Maya Schenwar on Grassroots Journalism
Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production.
View all episodes
By Fairness & Accuracy In Reporting
4.8
487487 ratings
Paxlovid's "transition" to the commercial market entails hiking the cost of the treatment to 100 times the cost of production.
More shows like CounterSpin
View all
Behind the News with Doug Henwood
482 Listeners
Democracy Now! Audio
5,667 Listeners
Democracy Now! Video
1,089 Listeners
Jacobin Radio
1,402 Listeners
Ralph Nader Radio Hour
1,188 Listeners
The Electronic Intifada Podcast
266 Listeners
The Dig
1,486 Listeners
Economic Update with Richard D. Wolff
1,958 Listeners
Scheer Intelligence
389 Listeners
The Nation Podcasts
383 Listeners
The Intercept Briefing
6,116 Listeners
Citations Needed
3,864 Listeners
Deconstructed
4,256 Listeners
Lever Time
508 Listeners
The Chris Hedges Report
52 Listeners